{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:04:35Z","timestamp":1773936275862,"version":"3.50.1"},"reference-count":61,"publisher":"China Science Publishing & Media Ltd.","issue":"8","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2014,8,1]]},"DOI":"10.1093\/abbs\/gmu051","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T02:45:02Z","timestamp":1404787502000},"page":"682-690","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":18,"title":["Silencing RhoA inhibits migration and invasion through Wnt\/&amp;beta;-catenin pathway and growth through cell cycle regulation in human tongue cancer"],"prefix":"10.3724","volume":"46","author":[{"given":"Guoxin","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronghai","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenggang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weina","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin O.","family":"Bergo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Dalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"Jemal A","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin, 2009, 59: 225-249.","journal-title":"CA Cancer J Clin"},{"key":"null","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"Kamangar F","year":"2006","unstructured":"Kamangar F, Dores GM, Anderson WF. Pattern of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 2006, 24: 2137-2150.","journal-title":"J Clin Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"412908","DOI":"10.1155\/2009\/412908","volume":"2009","author":"Ferrari D","year":"2009","unstructured":"Ferrari D, Codeca C, Fiore J, Moneghini L, Bosari S, Foa P. Biomolecular markers in cancer of the tongue. J Oncol, 2009, 2009:","journal-title":"J Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-007-9082-y","volume":"26","author":"Sano D","year":"2007","unstructured":"Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev, 2007, 26: 645-662.","journal-title":"Cancer Metastasis Rev"},{"key":"null","first-page":"278","volume":"93","author":"Kruaysawat W","year":"2010","unstructured":"Kruaysawat W, Aekplakorn W, Chapman RS. Survival time and prognostic factors of oral cancer in Ubon Ratchathani Cancer Center. J Med Assoc Thai, 2010, 93: 278-284.","journal-title":"J Med Assoc Thai"},{"key":"null","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1007\/s12032-010-9737-3","volume":"28","author":"Wang YH","year":"2011","unstructured":"Wang YH, Wu MW, Yang AK, Zhang WD, Sun J, Liu TR, Chen YF. COX-2 gene increases tongue cancer cell proliferation and invasion tongue VEGF-C pathway. Med Oncol, 2011, 28: S360-S366.","journal-title":"Med Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","volume":"21","author":"Jaffe AB","year":"2005","unstructured":"Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol, 2005, 21: 247-269.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/molbev\/msl145","volume":"24","author":"Boureux A","year":"2007","unstructured":"Boureux A, Vignal E, Faure S, Fort P. Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol Biol Evol, 2007, 24: 203-216.","journal-title":"Mol Biol Evol"},{"key":"null","doi-asserted-by":"crossref","first-page":"e66275","DOI":"10.1371\/journal.pone.0066275","volume":"8","author":"Ma J","year":"2013","unstructured":"Ma J, Xue Y, Liu W, Yue C, Bi F, Xu J, Zhang J. Role of activated rac1\/cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. PLoS ONE, 2013, 8:","journal-title":"PLoS ONE"},{"key":"null","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4161\/cib.21633","volume":"5","author":"Hwang Y","year":"2012","unstructured":"Hwang Y, Gouget CL, Barakat AI. Mechanisms of cytoskeleton-mediated mechanical signal transmission in cells. Commun Integr Biol, 2012, 5: 538-542.","journal-title":"Commun Integr Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yexcr.2004.08.012","volume":"301","author":"Wheeler AP","year":"2004","unstructured":"Wheeler AP, Ridley AJ. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res, 2004, 301: 43-49.","journal-title":"Exp Cell Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","volume":"81","author":"Takai Y","year":"2001","unstructured":"Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev, 2001, 81: 153-208.","journal-title":"Physiol Rev"},{"key":"null","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrm2476","volume":"9","author":"Heasman SJ","year":"2008","unstructured":"Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol, 2008, 9: 690-701.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"null","first-page":"125","volume":"53","author":"Shimada T","year":"2007","unstructured":"Shimada T, Nishimura Y, Nishiuma T, Rikitake Y, Hirase T, Yokoyama M. Adenoviral transfer of Rho family proteins to lung cancer cells ameliorates cell proliferation and motility and increases apoptotic change. Kobe J Med Sci, 2007, 53: 125-134.","journal-title":"Kobe J Med Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2008.05.045","volume":"440","author":"Fan YM","year":"2008","unstructured":"Fan YM, Pang CP, Harvey AR, Cui Q. Marked effect of RhoA-specific shRNA-producing plasmids on neurite growth in PC12 cells. Neurosci Lett, 2008, 440: 170-175.","journal-title":"Neurosci Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s13277-012-0417-0","volume":"33","author":"Wu Z","year":"2012","unstructured":"Wu Z, Wu Z, Li J, Yang X, Wang Y, Yu Y. MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells. Tumor Biol, 2012, 33: 1619-1628.","journal-title":"Tumor Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1038\/onc.2011.476","volume":"31","author":"Liao YC","year":"2012","unstructured":"Liao YC, Ruan JW, Lua I, Li MH, Chen WL, Wang JR. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1\/RhoA signaling. Oncogene, 2012, 31: 3086-3097.","journal-title":"Oncogene"},{"key":"null","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1038\/onc.2010.326","volume":"29","author":"Ma Z","year":"2010","unstructured":"Ma Z, Liu Z, Wu RF, Terada LS. p66Shc(Shc) restrains Ras hyperactivation and suppresses metastatic behavior. Oncogene, 2010, 29: 5559-5567.","journal-title":"Oncogene"},{"key":"null","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1756-9966-29-123","volume":"29","author":"Wang H","year":"2010","unstructured":"Wang H, Zhao G, Liu X, Sui A, Yang K, Yao R, Wang Z. Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo. J Exp Clin Cancer Res, 2010, 29:","journal-title":"J Exp Clin Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oraloncology.2012.07.003","volume":"49","author":"Chang KW","year":"2013","unstructured":"Chang KW, Kao SY, Wu YH, Tsai MM, Tu HF, Liu CJ, Lui MT. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Oral Oncol, 2013, 49: 27-33.","journal-title":"Oral Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.1158\/0008-5472.CAN-06-2646","volume":"66","author":"Pan Q","year":"2006","unstructured":"Pan Q, Bao LW, Teknos TN, Merajver SD. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res, 2006, 66: 9379-9384.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1128\/MCB.00249-10","volume":"30","author":"Croucher DR","year":"2010","unstructured":"Croucher DR, Rickwood D, Tactacan CM, Musgrove EA, Daly RJ. Cortactin modulate RhoA activation and expression of Cip\/Kip Cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells. Mol Cell Biol, 2010, 30: 5057-5070.","journal-title":"Mol Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/01.sla.0000140755.97224.9a","volume":"240","author":"Duxbury MS","year":"2004","unstructured":"Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, Whang EE. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. Ann Surg, 2004, 240: 667-674.","journal-title":"Ann Surg"},{"key":"null","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/or.2012.1890","volume":"28","author":"Wu B","year":"2012","unstructured":"Wu B, Li S, Sheng L, Zhu J, Gu L, Shen H, La D. Metformin inhibits the development and metastasis of ovarian cancer. Oncol Rep, 2012, 28: 903-908.","journal-title":"Oncol Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.4081\/ejh.2012.e25","volume":"56","author":"Santoro A","year":"2012","unstructured":"Santoro A, Pannone G, Errico ME, Bifano D, Lastilla G, Bufo P, Loreto C. Role of \u03b2-catenin expression in paediatric mesenchymal lesions: a tissue microarray-based immunohistochemical study. Eur J Histochem, 2012, 56:","journal-title":"Eur J Histochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0002-9610(05)80333-2","volume":"166","author":"Franceschi D","year":"1993","unstructured":"Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg, 1993, 166: 360-365.","journal-title":"Am J Surg"},{"key":"null","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0002-9610(89)90122-0","volume":"158","author":"Fakih AR","year":"1989","unstructured":"Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg, 1989, 158: 309-313.","journal-title":"Am J Surg"},{"key":"null","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(01)00412-8","volume":"165","author":"Aznar S","year":"2001","unstructured":"Aznar S, Lacal JC. Rho signals to cell growth and apoptosis. Cancer Lett, 2001, 165: 1-10.","journal-title":"Cancer Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0955-0674(03)00097-8","volume":"15","author":"Fukata M","year":"2003","unstructured":"Fukata M, Nakagawa M, Kaibuchi K. Roles of Rho-family GTPases in cell polarization and directional migration. Curr Opin Cell Biol, 2003, 15: 590-597.","journal-title":"Curr Opin Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/00005537-200107000-00027","volume":"111","author":"Abraham MT","year":"2001","unstructured":"Abraham MT, Kuriakose MA, Sacks PG, Yee H, Chiriboga L, Bearer EL. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope, 2001, 111: 1285-1289.","journal-title":"Laryngoscope"},{"key":"null","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/B:BREA.0000018424.43445.f3","volume":"84","author":"Lin M","year":"2004","unstructured":"Lin M, van Golen KL. Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Res Treat, 2004, 84: 49-60.","journal-title":"Breast Cancer Res Treat"},{"key":"null","first-page":"6130","volume":"50","author":"Fidler IJ","year":"1990","unstructured":"Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth GHA Clowes Memorial Award Lecture. Cancer Res, 1990, 50: 6130-6138.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/0008-5472.CAN-05-3116","volume":"66","author":"Fiordalisi JJ","year":"2006","unstructured":"Fiordalisi JJ, Keller PJ, Cox AD. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res, 2006, 66: 3153-3161.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/gast.2002.31093","volume":"122","author":"Kusama T","year":"2002","unstructured":"Kusama T, Mukai M, Iwasaki T, Tatsuta M, Matsumoto Y, Akedo H, Inoue M. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. Gastroenterology, 2002, 122: 308-317.","journal-title":"Gastroenterology"},{"key":"null","first-page":"943","volume":"19","author":"Dunne AA","year":"2005","unstructured":"Dunne AA, Mandic R, Falkenberg S, Dalchow CV, Sesterhenn AM, Werner JA. RT-PCR expression profiling of matrix metalloproteinases and their specific inhibitors in cell lines and fresh biopsies of squamous cell carcinomas of the head and neck. In Vivo, 2005, 19: 943-948.","journal-title":"In Vivo"},{"key":"null","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1158\/1078-0432.CCR-03-0530","volume":"10","author":"Ruokolainen H","year":"2004","unstructured":"Ruokolainen H, Paakko P, Turpeenniemi-Hujanen T. Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis. Clin Cancer Res, 2004, 10: 3110-3116.","journal-title":"Clin Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/aps.2012.150","volume":"34","author":"Zhang D","year":"2013","unstructured":"Zhang D, Chen ZG, Liu SH, Dong ZQ, Dalin M, Bao SS, Hu YW. Galectin-3 silencing inhibits migration and invasion of human tongue cancer cells via downregulation of \u03b2-catenin. Acta Pharmacol Sin, 2013, 34: 176-184.","journal-title":"Acta Pharmacol Sin"},{"key":"null","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1038\/sj.onc.1203703","volume":"19","author":"Leethanakul C","year":"2000","unstructured":"Leethanakul C, Patel V, Gillespie J, Pallente M, Ensly JF, Koontongkaew S, Liotta LA. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene, 2000, 19: 3220-3224.","journal-title":"Oncogene"},{"key":"null","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/154405910408300411","volume":"83","author":"Uraguchi M","year":"2004","unstructured":"Uraguchi M, Morikawa M, Shirakawa M, Sanada K, Lmai K. Activation of WNT family expression and signaling in squamous cell carcinoma of the oral cavity. J Dent Res, 2004, 83: 327-332.","journal-title":"J Dent Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4142\/jvs.2009.10.3.177","volume":"10","author":"Lee J","year":"2009","unstructured":"Lee J, Moon C, Kim J, Jung C, Lee KH, Joo HG, Ahn M. Immunohistochemical localization of galectin-3 in the granulomatous lesions of paratuberculosis-infected bovine intestine. J Vet Sci, 2009, 10: 177-180.","journal-title":"J Vet Sci"},{"key":"null","first-page":"235","volume":"13","author":"Shibata T","year":"2005","unstructured":"Shibata T, Noguchi T, Takeno S, Takahashi Y, Fumoto S, Kawahara K. Impact of nuclear galectin-3 expression on histological differentiation and vascular invasion in patients with esophageal squamous cell carcinoma. Oncol Rep, 2005, 13: 235-239.","journal-title":"Oncol Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0016-5085(97)70010-6","volume":"113","author":"Sanjuan X","year":"1997","unstructured":"Sanjuan X, Fernandez PL, Castells A, Castronovo V, van den Brule F, Liu FT, Cardesa A. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology, 1997, 113: 1906-1915.","journal-title":"Gastroenterology"},{"key":"null","first-page":"4635","volume":"6","author":"Honjo Y","year":"2000","unstructured":"Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, Hattori K. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res, 2000, 6: 4635-4640.","journal-title":"Clin Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tcb.2005.03.002","volume":"15","author":"Harris TJC","year":"2005","unstructured":"Harris TJC, Peifer M. Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol, 2005, 15: 234-237.","journal-title":"Trends Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"e25402","DOI":"10.1371\/journal.pone.0025402","volume":"6","author":"Sommer G","year":"2011","unstructured":"Sommer G, Rossa C, Chi AC, Neville BW, Heise T. Implication of RNA-binding protein La in proliferation, migration and invasion of lymph node-metastasized hypopharyngeal SCC cells. PLoS ONE, 2011, 6:","journal-title":"PLoS ONE"},{"key":"null","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12253-013-9603-7","volume":"19","author":"Wang LP","year":"2013","unstructured":"Wang LP, Chen SW, Zhuang SM, Li H, Song M. Galectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt\/\u03b2-catenin-dependent pathway. Pathol Oncol Res, 2013, 19: 461-474.","journal-title":"Pathol Oncol Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.bbamcr.2013.04.017","volume":"1832","author":"Santiago-Gomez A","year":"2013","unstructured":"Santiago-Gomez A, Barrasa JI, Olmo N, Lecona E, Burghardt H, Palacin M, Lizarbe MA. 4F2hc-silencing impairs tumorigenicity of HeLa cells via modulation of galectin-3 and \u03b2-catenin signaling, and MMP-2 expression. Biochim Biophys Acta, 2013, 1832: 2045-2056.","journal-title":"Biochim Biophys Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3892\/or.2012.1945","volume":"28","author":"Webb SL","year":"2012","unstructured":"Webb SL, Sanders AJ, Mason MD, Jiang WG. The influence of matriptase-2 on prostate cancer in vitro: a possible role for \u03b2-catenin. Oncol Rep, 2012, 28: 1491-1497.","journal-title":"Oncol Rep"},{"key":"null","first-page":"211","volume":"11","author":"Grana X","year":"1995","unstructured":"Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CDKIs). Oncogene, 1995, 11: 211-219.","journal-title":"Oncogene"},{"key":"null","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1006\/jmbi.1999.2640","volume":"287","author":"Pavletich NP","year":"1999","unstructured":"Pavletich NP. Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and CIP and INK4 inhibitors. J Mol Biol, 1999, 287: 821-828.","journal-title":"J Mol Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12032-010-9774-y","volume":"29","author":"Ma J","year":"2012","unstructured":"Ma J, Zhang J, Ma Y, Zeng J, Cheng Y, Xue Y, Liu W. Adenovirus-mediated RhoA shRNA suppresses growth of esophageal squamous cell carcinoma cells in vitro and in vivo. Med Oncol, 2012, 29: 119-126.","journal-title":"Med Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-5793(00)01491-5","volume":"473","author":"Raisova M","year":"2000","unstructured":"Raisova M, Bektas M, Wieder T, Daniel P, Eberle J, Orfanos CE, Geilen CC. Resistance to CD95\/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. FEBS Lett, 2000, 473: 27-32.","journal-title":"FEBS Lett"},{"key":"null","first-page":"3200","volume":"62","author":"Sauter ER","year":"2002","unstructured":"Sauter ER, Yeo UC, von Stemm A, Zhu W, Litwin S, Tichansky DS, Pistritto G. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res, 2002, 62: 3200-3206.","journal-title":"Cancer Res"},{"key":"null","first-page":"409","volume":"22","author":"Choi HR","year":"2003","unstructured":"Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and ki-67 in oral squamous tumorigenesis. Int J Oncol, 2003, 22: 409-414.","journal-title":"Int J Oncol"},{"key":"null","first-page":"711","volume":"44","author":"Koufos A","year":"1989","unstructured":"Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalbakji A. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet, 1989, 44: 711-719.","journal-title":"Am J Hum Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s004280050445","volume":"435","author":"Kuropkat C","year":"1999","unstructured":"Kuropkat C, Rudolph P, Frahm SO, Parwaresch R, Werner JA. Proliferation marker Ki-S11-a prognostic indicator for squamous cell carcinoma of the hypopharynx. Virchows Arch, 1999, 435: 590-595.","journal-title":"Virchows Arch"},{"key":"null","first-page":"2266","volume":"55","author":"Kawamata N","year":"1995","unstructured":"Kawamata N, Moroseti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27\/kip1 in human malignancies. Cancer Res, 1995, 55: 2266-2269.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1011::AID-CNCR1>3.0.CO;2-0","volume":"85","author":"Mineta H","year":"1999","unstructured":"Mineta H, Miura K, Suzuki I, Takebayashi S, Amano H, Araki K, Harada H. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer, 1999, 85: 1011-1017.","journal-title":"Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3835(99)00419-X","volume":"151","author":"Kudo Y","year":"2000","unstructured":"Kudo Y, Takata T, Ogawa I, Zhao M, Sato S, Takekoshi T, Miyauchi M. Reduced expression of p27(Kip1) correlates with an early stage of cancer invasion in oral squamous cell carcinoma. Cancer Lett, 2000, 151: 217-222.","journal-title":"Cancer Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-4598-11-17","volume":"11","author":"Wang Z","year":"2012","unstructured":"Wang Z, Sturgis EM, Zhang F, Lei D, Liu Z, Xu L, Song X. Genetic variant of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck. Mol Cancer, 2012, 11:","journal-title":"Mol Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/369574a0","volume":"369","author":"Waga S","year":"1994","unstructured":"Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 1994, 369: 574-578.","journal-title":"Nature"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/4AC875A9023F4667A6DB2E42878077DD","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmu051","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/4AC875A9023F4667A6DB2E42878077DD","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T01:52:18Z","timestamp":1689385938000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmu051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,1]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmu051","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8,1]]}}}